SAB Biotherapeutics
SABS
SABS
34 hedge funds and large institutions have $2.41M invested in SAB Biotherapeutics in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 7 closing their positions.
Holders
34
Holders Change
-4
Holders Change %
-10.53%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
7
Reduced
2
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
